Beyond Ozempic: New GLP-1 drugs promise weight loss and …
Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound. Some of the experimental drugs may...
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug, …
May 10, 2024 · About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people –...
New study ties weight-loss drugs Wegovy, Ozempic to serious ...
Oct 5, 2023 · Shortage of diabetes, weight-loss drug Ozempic expected in Canada, says manufacturer. THE CURRENT. Canadians are taking Ozempic, but stigma around weight stops them talking about it. GLP-1 drugs...
GLP-1s like Ozempic are among the most important drug …
Oct 24, 2024 · A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists.
Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic
Jul 23, 2024 · Semaglutide -- the drug sold as Ozempic and Wegovy -- is being prescribed disproportionately to females, whites, and those with a BMI of 30 or more, indicating obesity, results show.
More fiber in the diet may help boost levels of GLP-1, an Ozempic …
Oct 30, 2023 · Turns out, the answer is yes – you can increase your body's production of GLP-1 with your diet, says Frank Duca, who studies metabolic diseases at the University of Arizona.
How Ozempic, other weight-loss drugs are "changing medicine"
Jan 21, 2024 · Ozempic and Mounjaro (used for diabetes), and Wegovy and Zepbound (approved for weight loss), are GLP-1 drugs. According to Dr. Rekha Kumar, the GLP-1 class of medicines signals fullness...
‘GLP-1’ Has Become an Empty Buzzword - The Atlantic
Oct 16, 2024 · The new blockbuster obesity drugs, made famous by Ozempic, are collectively known as GLP-1 agonists, for the hormone they mimic in the body: glucagon-like peptide 1.
The Race for the Next Ozempic - WIRED
Jul 24, 2024 · Semaglutide and tirzepatide work by activating GLP-1 receptors in the pancreas to stimulate the production of insulin, which helps to control blood sugar levels in people with type 2 diabetes.
As Semaglutide’s Popularity Soars, Rare but Serious Adverse …
This Medical News article discusses Wegovy, Ozempic, and other GLP-1 receptor agonists used for weight management and type 2 diabetes.